Abstract: A motor vibration control device includes a speed adjusting unit for outputting a driving torque reference value based on the difference between a speed reference value to a motor and a detected speed value of the motor; a current adjusting unit for adjusting the current to be provided for the motor and outputting a driving torque value based on the current; a compensation torque calculator for calculating a compensation torque value based on the detected speed value, the driving torque reference value, and the driving torque value; an amplifying unit for amplifying the compensation torque value; and an adder for adding the driving torque reference value to the amplified compensation torque value and outputting the sum to the current adjusting unit. With this simple circuit configuration, the device suppresses the torsional vibration generated by an operating motor.
Abstract: Solutions useful for hybridizing cells and viruses with nucleic acid and antibody probes, their usefulness increased due to the presence of permeation enhancers and signal enhancers, including permeation enhancers; also the hybridization processes wherein the solutions are used.
Type:
Grant
Filed:
July 17, 1992
Date of Patent:
May 28, 1996
Assignee:
Aprogenex, Inc.
Inventors:
Joel Bresser, Michael L. Cubbage, Nagindra Prashad, William D. Weber, Shyh Chen Ju
Abstract: A system is disclosed for the automation of virtually all clerical functions in an office, such as for example, an insurance agency. Virtually any document generated by the office may be printed without the need for pre-printed forms, as the system prints such forms on a laser printer near the worker requesting the form, using a page description language (PDL) appropriate to the printer. The clerical activity involved in maintaining, updating, retrieving, displaying and printing information relating to the functions of the office is supported. A complete audit history of all activity to a specific database (DB) file record is maintained without saving the entire DB record in a historical file. The system also supports a worker when it is desired to interrupt a particular task and execute a different task, without losing information already entered for the first task, but without allowing the worker to exit the system without completing or accounting for the first task.
Abstract: An exercise apparatus adapted to provide resistance to an exercising user who attempts to induce an exercise stroke of the apparatus and which is also adapted so that once the exercising user has initiated the exercise stroke along the stroke path the user may: (1) continue to exert a force along the stroke path; (2) exert a force opposite the exercise stroke path, this force will also be resisted by the apparatus; (3) exert no force, in which case the apparatus will continue the exercise stroke path; or (4) the user may initiate some combination of the above actions. The exercise apparatus being further adapted so that gravity and friction do not have a significant effect on the resistance or assistance that the user confronts. Embodiments of the invention encompass exercise stroke paths in up to three dimensions, whereby the user may perform linear, rotational, or a combination of both movements in exercising with the apparatus.
Abstract: Assays for target molecules in and from cells and viruses, e.g. nucleic acids, wherein non-specific background is decreased by including an analogue of the reporter group, e.g. a non-fluorescent analogue such as fuchsin, of a fluorescent group such as fluorescein, to decrease non-specific backround.
Type:
Grant
Filed:
January 14, 1994
Date of Patent:
March 26, 1996
Assignee:
Aprogenex, Inc.
Inventors:
Michael L. Cubbage, Joel Bresser, Mark Blick, Shyh C. Ju
Abstract: A method for isolating nucleated fetal erythrocytes (NFEs) from a maternal blood sample by separating erythrocytes in the maternal blood sample from all other nucleated cells therein using a leukocyte depletion device; and isolating NFEs from nonnucleated maternal erythrocytes. Preferably the maternal blood is peripheral maternal blood. The isolated NFEs can then be analyzed for genetic disorders and the like, such as by in situ hybridization.